EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US Adults

Kate Penrose, Avantika Srivastava, Yanhan Shen, McKaylee M Robertson, Sarah G Kulkarni, Kristen E Allen, Thomas M Porter, Laura Puzniak, John M McLaughlin, Denis Nash

Infectious Diseases and Therapy · 2024-08 · 13 (8) · 1743-1757

DOI: 10.1007/s40121-024-01003-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infectious Diseases and Therapy, online erschienen am 23.06.2024. Verfasst von Kate Penrose und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), 55 W. 125 Street, 6 Floor, New York, NY, 10027,…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

COVID-19Oral antiviral usePerceived risk

Autor:innen und Institutionen

  • Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), 55 W. 125 Street, 6 Floor, New York, NY, 10027, USA. kate.penrose@sph.cuny.edu.
  • Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), 55 W. 125 Street, 6 Floor, New York, NY, 10027, USA.
  • Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, NY, USA.
  • Pfizer Inc., New York, NY, USA.

Förderung

  • Pfizer

Zitieren

APA

Penrose, K., Srivastava, A., Shen, Y., Robertson, M. M., Kulkarni, S. G., Allen, K. E., Porter, T. M., Puzniak, L., McLaughlin, J. M., & Nash, D. (2024). Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US Adults. Infectious Diseases and Therapy, 13(8), 1743-1757. https://doi.org/10.1007/s40121-024-01003-3

Vancouver

Penrose K, Srivastava A, Shen Y, Robertson MM, Kulkarni SG, Allen KE, et al. Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US Adults. Infectious Diseases and Therapy. 2024;13(8):1743-1757. doi:10.1007/s40121-024-01003-3

BibTeX
@article{Penrose2024,
  author = {Penrose, Kate and Srivastava, Avantika and Shen, Yanhan and Robertson, McKaylee M and Kulkarni, Sarah G and Allen, Kristen E and Porter, Thomas M and Puzniak, Laura and McLaughlin, John M and Nash, Denis},
  title = {Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US Adults},
  journal = {Infectious Diseases and Therapy},
  year = {2024},
  volume = {13},
  number = {8},
  pages = {1743--1757},
  doi = {10.1007/s40121-024-01003-3}
}
Kostenlos starten →